United States Food and Drug Administration
PulseAugur coverage of United States Food and Drug Administration — every cluster mentioning United States Food and Drug Administration across labs, papers, and developer communities, ranked by signal.
- subsidiary of United States Department of Health and Human Services 100%
- parent of Center for Biologics Evaluation and Research 100%
- parent of Center for Drug Evaluation and Research 100%
- parent of Center for Devices and Radiological Health 100%
- instance of daraxonrasib 95%
- instance of COVID-19 90%
- instance of BPC-157 90%
- employed by Kyle Diamantas 90%
- acquired Eli Lilly and Company 90%
- developed by daraxonrasib 90%
- used by Samsung Galaxy Watch 90%
- developed by Revolution Medicines (United States) 90%
- 2026-11-06 regulatory The FDA has cleared four blood tests for the detection of Alzheimer's disease. source
- 2026-10-28 regulatory The FDA conducted only 5% of its planned foreign food inspections last year, leading to decreased public confidence in food safety. source
- 2026-10-24 regulatory The FDA is holding discussions on generative AI in medical devices, with healthcare provider groups advocating for developer liability. source
- 2026-10-01 regulatory The FDA is investigating the supplement kratom due to health concerns. source
- 2026-09-14 regulatory U.S. health officials are rapidly deploying medical AI, including within Medicare, with the involvement of the United States Food and Drug Administration. source
- 2026-08-19 hiring Donald Trump intends to nominate Heidi Overton to be the next commissioner of the United States Food and Drug Administration. source
- 2026-08-17 regulatory The FDA classified nearly 19 million eggs under its highest risk category due to potential Salmonella contamination. source
- 2026-08-17 regulatory The FDA proposed a new rule to mandate pre-market notification for new food ingredients. source
- 2026-08-14 research_milestone Researchers propose a human-algorithm approach to improve the FDA's medical device clearance policy, potentially reducing recalls and workload. source
- 2026-08-11 regulatory The FDA proposed a rule change requiring food manufacturers to notify regulators before introducing new ingredients or additives. source
- 2026-07-24 regulatory A panel of FDA advisers narrowly recommended easing restrictions on several peptides, despite warnings from government scientists. source
- 2026-07-23 product_launch The FDA launched an AI platform that is now used daily by 85% of its staff. source
- 2026-07-22 regulatory An FDA panel is reviewing seven peptides, with a decision on their potential legalization expected soon. source
- 2026-07-21 regulatory The FDA is reviewing seven peptides for potential compounding approval, facing scrutiny over safety and efficacy claims. source
- 2026-07-21 regulatory The FDA's Pharmacy Compounding Advisory Committee will review seven peptides to determine their eligibility for compounding. source
21 day(s) with sentiment data
-
FDA flags AI and cyber risks in autonomous medical robots
The United States Food and Drug Administration (FDA) has flagged potential cybersecurity and AI risks associated with autonomous medical robots. Experts are concerned about the threat of cyberattacks to patient safety a…
-
Congress urged to form bipartisan health and science caucus
A call is being made for a bipartisan caucus in Congress focused on health and science. The aim is to prioritize scientific integrity and evidence-based policymaking over partisan politics. This initiative seeks to ensu…
-
Access to investigational treatments is hampered by systemic barriers, not science
Access to investigational treatments, rather than scientific breakthroughs alone, is crucial for driving impact in healthcare. Despite patient willingness, significant gaps exist in clinical trial participation due to i…
-
Regulators demand proof of call connectivity, including AI agents
Regulators in healthcare, pharmaceuticals, and banking are increasingly scrutinizing voice channels, including those managed by AI agents, to ensure critical calls can connect and be properly logged. A recent test of ne…
-
OnePlus and Amazfit smartwatches offer strong battery life and value, but with app limitations
OnePlus smartwatches are praised for their exceptional battery life and fast charging capabilities, offering a durable build and competitive pricing. However, they lack cellular support and are incompatible with iPhones…
-
Orinyx releases open-source tool to verify AI medication claims against FDA labels
Orinyx has released version 0.1.4 of its open-source Medication Claims Processor (MCP) tool, which verifies AI agent medication claims against FDA label text. This update primarily focuses on documentation improvements,…
-
US FDA probes tumor risk in Novartis gene therapy Zolgensma
The U.S. Food and Drug Administration (FDA) is investigating potential tumor risks associated with Novartis' gene therapy, Zolgensma. This investigation follows reports of neoplasia, including malignancy, in children tr…
-
GLPcompare launches public API for GLP-1 cash prices
GLPcompare has launched a free, public Model Context Protocol (MCP) server to provide AI assistants with access to US GLP-1 cash prices. This server, accessible via a read-only HTTP endpoint, offers real-time pricing da…
-
AI's Medical Promises Questioned by Drugmakers; Expert Witness Guidance Issued
Drugmaker CEOs are skeptical that artificial intelligence will revolutionize medicine, citing that no AI-designed drug has yet received FDA approval. They believe biological complexity remains a significant hurdle. Sepa…
-
FDA Clears Four Alzheimer's Blood Tests for Disease Detection
The U.S. Food and Drug Administration (FDA) has approved four distinct blood tests designed to detect Alzheimer's disease. These tests measure specific biomarkers, offering insights into the presence of senile plaques a…
-
Democrats to launch health care investigations post-Congress takeover
Democrats are poised to launch extensive health care investigations and oversight hearings following their takeover of Congress. Key priorities include probing potential political interference in vaccine policies and ex…
-
Samsung's Galaxy Ring gains FDA approval for AI-powered sleep apnea detection
Samsung has received FDA approval for an advanced sleep apnea detection feature on its Galaxy Ring and Galaxy Watch devices. This new AI-powered functionality analyzes breathing disruptions per hour of sleep, providing …
-
FDA eyes artificial womb tech after lamb experiments
The United States Food and Drug Administration (FDA) is reportedly considering advancements in artificial womb technology, following successful experiments where eight lambs were sustained for four weeks in plastic bags…
-
AI poised to revolutionize healthcare, but data quality remains a hurdle
The current healthcare system struggles to keep pace with advancements in AI and data analysis, leading to suboptimal patient care. While cutting-edge treatments are available, the underlying infrastructure for managing…
-
Leman Biotech's low-dose CAR-T therapy shows 100% remission rate
Leman Biotech has developed a novel CAR-T cell therapy that utilizes a significantly lower dosage, just 1‰ of the conventional amount, while achieving remarkable efficacy. This approach, which involves metabolically enh…
-
LLMs give different smoking cessation advice based on user persona
A new arXiv paper investigates how six large language models (LLMs) provide different health advice based on user personas, particularly concerning smoking cessation. The study found that models frequently offered less …
-
FDA seeks Tavneos approval withdrawal over manipulated data; seabirds may suffer jet lag
The FDA is seeking to withdraw its approval for the drug Tavneos, alleging that the study data used for its initial approval was manipulated. This action raises questions about continued patient access to the medication…
-
Amazon Echo Show 16 aims to be a smart calendar; Samsung enhances Galaxy Watch sleep tracking
Amazon's Echo Show 16 is being highlighted as a potential smart calendar solution, offering organizational features for families. Separately, Samsung is enhancing its Galaxy Watches with improved sleep tracking capabili…
-
Higgs Bio's AI-developed cancer drug nominated for Prix Galien award
Higgs Bio, a company incubated by Crystal Pharma, has been nominated for the Prix Galien USA for its AI-developed diffuse gastric cancer targeted drug, SIGX1094. This nomination highlights the success of their "AI + Org…
-
Alzheimer's treatments advance, but early diagnosis remains critical
New Alzheimer's treatments like lecanemab and donanemab are offering hope, but early diagnosis remains a significant hurdle. Experts highlight the need for improved diagnostic tools and accessibility to ensure patients …